A randomized controlled trial to treat impaired learning and memory in multiple sclerosis: The self-GEN trial.

Yael Goverover, Nancy Chiaravalloti, Helen Genova, John DeLuca

Research output: Contribution to journalArticle

Abstract

BACKGROUND:
Difficulties in learning and memory are among the most persistent and frequently reported cognitive symptoms in individuals with multiple sclerosis (MS).
OBJECTIVE:
To examine the efficacy of the self-generation learning program ( self-GEN trial) that consist of behavioral intervention sessions, teaching self-generation technique while using metacognitive strategies to improve learning and memory abilities in persons with MS. Additionally, the treatment aimed to address generalization of the treatment to activities of daily living.
METHODS:
This double-blind, placebo-controlled, randomized clinical trial included 35 participants with clinically definite MS, 19 in the treatment group and 16 in the placebo control group. Participants completed a baseline neuropsychological assessment, including questionnaires assessing everyday memory and a repeat assessment immediately post-treatment.
RESULTS:
The treatment group showed significantly improved learning and memory, self-regulation, and metacognition relative to the placebo post-treatment. Similar results were noted on measures of depression, functional status, and quality of life (QOL).
CONCLUSION:
This study provides initial Class I evidence that the self-GEN behavioral intervention improves memory, self-regulation, functional status, affective symptomatology, and QOL in patients with MS.
Original languageEnglish (US)
JournalMultiple Sclerosis Journal
DOIs
StateE-pub ahead of print - May 9 2017

Fingerprint

Multiple Sclerosis
Randomized Controlled Trials
Learning
Placebos
Therapeutics
Quality of Life
Neurobehavioral Manifestations
Aptitude
Activities of Daily Living
Teaching
Depression
Control Groups
Self-Control

Keywords

  • cognition
  • memory
  • transfer
  • activities of daily living
  • multiple sclerosis
  • randomized clinical trial

Cite this

A randomized controlled trial to treat impaired learning and memory in multiple sclerosis: The self-GEN trial. / Goverover, Yael; Chiaravalloti, Nancy; Genova, Helen; DeLuca, John.

In: Multiple Sclerosis Journal, 09.05.2017.

Research output: Contribution to journalArticle

@article{8e591ee7054b44ff82ea7f327372e9c2,
title = "A randomized controlled trial to treat impaired learning and memory in multiple sclerosis: The self-GEN trial.",
abstract = "BACKGROUND:Difficulties in learning and memory are among the most persistent and frequently reported cognitive symptoms in individuals with multiple sclerosis (MS).OBJECTIVE:To examine the efficacy of the self-generation learning program ( self-GEN trial) that consist of behavioral intervention sessions, teaching self-generation technique while using metacognitive strategies to improve learning and memory abilities in persons with MS. Additionally, the treatment aimed to address generalization of the treatment to activities of daily living.METHODS:This double-blind, placebo-controlled, randomized clinical trial included 35 participants with clinically definite MS, 19 in the treatment group and 16 in the placebo control group. Participants completed a baseline neuropsychological assessment, including questionnaires assessing everyday memory and a repeat assessment immediately post-treatment.RESULTS:The treatment group showed significantly improved learning and memory, self-regulation, and metacognition relative to the placebo post-treatment. Similar results were noted on measures of depression, functional status, and quality of life (QOL).CONCLUSION:This study provides initial Class I evidence that the self-GEN behavioral intervention improves memory, self-regulation, functional status, affective symptomatology, and QOL in patients with MS.",
keywords = "cognition, memory, transfer, activities of daily living, multiple sclerosis, randomized clinical trial",
author = "Yael Goverover and Nancy Chiaravalloti and Helen Genova and John DeLuca",
year = "2017",
month = "5",
day = "9",
doi = "10.1177/1352458517709955",
language = "English (US)",
journal = "Multiple Sclerosis",
issn = "1352-4585",
publisher = "SAGE Publications Ltd",

}

TY - JOUR

T1 - A randomized controlled trial to treat impaired learning and memory in multiple sclerosis: The self-GEN trial.

AU - Goverover, Yael

AU - Chiaravalloti, Nancy

AU - Genova, Helen

AU - DeLuca, John

PY - 2017/5/9

Y1 - 2017/5/9

N2 - BACKGROUND:Difficulties in learning and memory are among the most persistent and frequently reported cognitive symptoms in individuals with multiple sclerosis (MS).OBJECTIVE:To examine the efficacy of the self-generation learning program ( self-GEN trial) that consist of behavioral intervention sessions, teaching self-generation technique while using metacognitive strategies to improve learning and memory abilities in persons with MS. Additionally, the treatment aimed to address generalization of the treatment to activities of daily living.METHODS:This double-blind, placebo-controlled, randomized clinical trial included 35 participants with clinically definite MS, 19 in the treatment group and 16 in the placebo control group. Participants completed a baseline neuropsychological assessment, including questionnaires assessing everyday memory and a repeat assessment immediately post-treatment.RESULTS:The treatment group showed significantly improved learning and memory, self-regulation, and metacognition relative to the placebo post-treatment. Similar results were noted on measures of depression, functional status, and quality of life (QOL).CONCLUSION:This study provides initial Class I evidence that the self-GEN behavioral intervention improves memory, self-regulation, functional status, affective symptomatology, and QOL in patients with MS.

AB - BACKGROUND:Difficulties in learning and memory are among the most persistent and frequently reported cognitive symptoms in individuals with multiple sclerosis (MS).OBJECTIVE:To examine the efficacy of the self-generation learning program ( self-GEN trial) that consist of behavioral intervention sessions, teaching self-generation technique while using metacognitive strategies to improve learning and memory abilities in persons with MS. Additionally, the treatment aimed to address generalization of the treatment to activities of daily living.METHODS:This double-blind, placebo-controlled, randomized clinical trial included 35 participants with clinically definite MS, 19 in the treatment group and 16 in the placebo control group. Participants completed a baseline neuropsychological assessment, including questionnaires assessing everyday memory and a repeat assessment immediately post-treatment.RESULTS:The treatment group showed significantly improved learning and memory, self-regulation, and metacognition relative to the placebo post-treatment. Similar results were noted on measures of depression, functional status, and quality of life (QOL).CONCLUSION:This study provides initial Class I evidence that the self-GEN behavioral intervention improves memory, self-regulation, functional status, affective symptomatology, and QOL in patients with MS.

KW - cognition

KW - memory

KW - transfer

KW - activities of daily living

KW - multiple sclerosis

KW - randomized clinical trial

U2 - 10.1177/1352458517709955

DO - 10.1177/1352458517709955

M3 - Article

JO - Multiple Sclerosis

JF - Multiple Sclerosis

SN - 1352-4585

ER -